Anteilseigner
Driehaus Capital Management LLC (6,63 %) Point72 Asset Management LP (6,28 %) BlackRock Fund Advisors (6,16 %) EcoR1 Capital, LLC (5,27 %) Fidelity Management & Research Co. LLC (4,96 %) T. Rowe Price Associates, Inc. (Investment Management) (4,74 %) The Vanguard Group, Inc. (4,39 %) SSgA Funds Management, Inc. (4,13 %) Paradigm BioCapital Advisors LP (3,96 %) Wellington Management Co. LLP (3,77 %) Jennison Associates LLC (3,57 %) T. Rowe Price Investment Management, Inc. (3,37 %) Janus Henderson Investors US LLC (2,47 %) First Light Asset Management LLC (2,14 %) Perceptive Advisors LLC (1,87 %) Geode Capital Management LLC (1,78 %) Invus Public Equities Advisors LLC (1,76 %) OrbiMed Advisors Private Equity (1,76 %) Bain Capital Life Sciences LP (1,62 %) Scott R. Struthers (1,47 %)
Kontakt
CRINETICS PHARMACEUTICALS INC